跳至主要内容
临床试验/IRCT20210105049944N1
IRCT20210105049944N1尚未招募2 期

The effectiveness of magnesium sulfate vaginal gel on cervical ripening and induction of labor in nulliparous women: a randomized controlled clinical trial

Ahvaz University of Medical Sciences0 个研究点目标入组 174 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
174

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
Female

入选标准

  • Desire to participate in the study
  • Being nulliparous
  • Mother age 18-40 years
  • Body mass index 18.5-25
  • Post date gestational age
  • Bishop score less than 4
  • Single fetus with cephalic presentation and intact membranes
  • Estimated weight of the fetus 2500-4000 grams
  • Low risk pregnancy
  • Indication of labor induction

排除标准

  • Risky underlying disease (anemia, blood disorders, heart or lung disease, connective tissue and smooth muscle problems)
  • History of any uterine scar
  • Refer with bleeding or rupture of membranes
  • Multiple pregnancy
  • Diagnosis of cephalopelvic disproportion by a physician
  • Contraindications to use of magnesium sulfate
  • Patient non-cooperation

研究者

相似试验

招募中
3 期
The effect of vaginal magnesium sulfate in preparing the cervix before labor inductio
IRCT20230612058462N1Ahvaz University of Medical Sciences104
招募中
3 期
Effect of magnesium sulfate on reducing the duration and pain of laborProlonged first stage (of labor).Prolonged first stage (of labor)O63.0
IRCT20230823059227N2Karaj University of Medical Sciences150
招募中
3 期
Effect of intravaginal application of magnesium sulfate on the intensity of labor pain, and the duration of the t first and second stages of labor in nulliparous women referred to Al-zahra hospitallabor facilitation.ICD-10 Pregnancy, childbirth and the puerperiumO00-O99
IRCT20200510047377N1Rasht University of Medical Sciences72
已完成
2 期
Effect of Complementary therapy of vaginal prebiotic gel with metronidazole tablet on treatment and recurrence of bacterial vaginosis: a randomized controlled trialCondition 1: Bacterial vaginosis. Condition 2: Bacterial vaginosis. Condition 3: Bacterial vaginosis.Female pelvic inflammatory disease, unspecifiedFemale pelvic inflammatory disorders in other diseases classified elsewhereOther specified inflammation of vagina and vulva
IRCT2015121721917N5Vice chancellor for research, Tabriz University of Medical Sciences100
尚未招募
4 期
Efficacy of DeflaGyn® vaginal gel in the treatment of suspicious cervical smear findings, related histopathological diagnoses CIN1 and CIN2 and the hr-HPV status: a post marketing clinical follow-up study.R87.6N87.0Mild cervical dysplasia
DRKS00030569Exeltis Germany GmbH70